We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-27.88%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.32B
AUM Growth
-$346M
Cap. Flow
-$15.1M
Cap. Flow %
-1.15%
Top 10 Hldgs %
59.82%
Holding
111
New
34
Increased
24
Reduced
9
Closed
40

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$69.5M
2
ENR icon
Energizer
ENR
+$56.7M
3
SRCL
Stericycle Inc
SRCL
+$40.3M
4
SGI
Somnigroup International
SGI
+$34.7M
5
WBT
Welbilt, Inc.
WBT
+$27.1M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$37.3M
2
HOG icon
Harley-Davidson
HOG
+$37.3M
3
HBI
Hanesbrands
HBI
+$36.9M
4
CPRI icon
Capri Holdings
CPRI
+$36.7M
5
CAR icon
Avis
CAR
+$32.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.78%
2 Consumer Discretionary 11.57%
3 Industrials 7.52%
4 Consumer Staples 5.7%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTCH
101
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
– –
-200,000
Closed -$5.45M
APRN
102
CALL
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
– –
-16,667
Closed -$5.16M
RDUS
103
DELISTED
Radius Health, Inc.
RDUS
– –
-658,000
Closed -$11.7M
TLRD
104
DELISTED
Tailored Brands, Inc.
TLRD
– –
-300,000
Closed -$7.56M
JCP
105
CALL
DELISTED
J.C. Penney Company, Inc.
JCP
– –
-2,300,000
Closed -$3.82M
ONCE
106
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-228,000
Closed -$12.4M
NVLN
107
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
– –
-1,856,000
Closed -$5.49M
IPCI
108
DELISTED
Intellipharmaceuticals International Inc.
IPCI
– –
-860,000
Closed -$2.31M
PDLI
109
DELISTED
PDL BioPharma, Inc.
PDLI
– –
-1,800,000
Closed -$4.73M
BDSI
110
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-3,292,000
Closed -$9.22M
1 2 3 4
5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Armistice Capital held 111 positions worth $1.32B, down 21% from $1.67B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Armistice Capital's Q4 2018 filing shows 34 new, 24 increased, 9 reduced and 40 closed positions. Its largest new stake was Energizer: 1,068,000 shares worth $48.2M. The largest sale was United Therapeutics, an estimated $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Armistice Capital's largest Q4 2018 buy was Energizer: 1,068,000 shares worth $48.2M.
  • Armistice Capital added most to Clovis Oncology, Inc. in Q4 2018, an estimated $69.5M increase.
  • Armistice Capital's biggest Q4 2018 reduction was J.M. Smucker, cutting an estimated $28.8M.
  • Armistice Capital fully exited United Therapeutics in Q4 2018, selling an estimated $37.3M.
  • Armistice Capital's ten largest holdings make up 60% of its $1.32B portfolio in Q4 2018.
  • Armistice Capital opened 34 new positions and closed 40 in Q4 2018.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $1.32B.

Based on Armistice Capital's 13F filing for Q4 2018, filed 14 Feb 2019.